Abstract:REAST CANCER SCREENING, ESpecially with mammography, has been recommended for many decades, 1 and the majority of women older than 40 years in the United States participate in screening activities. 2,3 Meanwhile, new screening modalities have been introduced, and some of these have been increasingly incorporated into community practice. However, none of the new technologies has been evaluated for its effect on breast cancer mortality. Community practice of screening may differ from the care provided within ran… Show more
“…Early detection of breast cancer plays the leading role in reducing mortality rates and improving the patients' prognosis among women (Elmore et al, 2005;Hoerger et al, 2011). In US, BC mortality rates are now decreasing because of the widely generalized use of mammography screening and the improvement in treatment (IARC., 2002).…”
Background: Breast cancer is the most commonly diagnosed cancer in women worldwide In Iran, it ranks first among cancers diagnosed in women and is the fifth most common cause of death. The aim of this study was to present the mortality trends from breast cancer for Iranian women during a period of almost a decade, in order to provide update information regarding the likely future. Methods: We analyzed National death Statistic reported by the Iranian Ministry of Health and Medical Education from 1995 to 2004 to generate annual mortality rates/100,000, overall, by age group (<15, 15-49 and ≥50 years of age) and age standardized rate (ASR). Results: The age standardized mortality rate of breast cancer increased dramatically during these years from 1.40 to 3.52 per 100,000 and its mortality was increasing 151.4% for Iranian women, although it seemed that the rate leveled off from 2002 to 2004. Moreover the increasing rate was higher for those aged between 15-49 compared to age >50 years old. Conclusion: There is an increasing trend for breast cancer mortality in Iran. Thus, health education programs to rectify the lack of women awareness about breast cancer signs and effective screening are urgently needed.
“…Early detection of breast cancer plays the leading role in reducing mortality rates and improving the patients' prognosis among women (Elmore et al, 2005;Hoerger et al, 2011). In US, BC mortality rates are now decreasing because of the widely generalized use of mammography screening and the improvement in treatment (IARC., 2002).…”
Background: Breast cancer is the most commonly diagnosed cancer in women worldwide In Iran, it ranks first among cancers diagnosed in women and is the fifth most common cause of death. The aim of this study was to present the mortality trends from breast cancer for Iranian women during a period of almost a decade, in order to provide update information regarding the likely future. Methods: We analyzed National death Statistic reported by the Iranian Ministry of Health and Medical Education from 1995 to 2004 to generate annual mortality rates/100,000, overall, by age group (<15, 15-49 and ≥50 years of age) and age standardized rate (ASR). Results: The age standardized mortality rate of breast cancer increased dramatically during these years from 1.40 to 3.52 per 100,000 and its mortality was increasing 151.4% for Iranian women, although it seemed that the rate leveled off from 2002 to 2004. Moreover the increasing rate was higher for those aged between 15-49 compared to age >50 years old. Conclusion: There is an increasing trend for breast cancer mortality in Iran. Thus, health education programs to rectify the lack of women awareness about breast cancer signs and effective screening are urgently needed.
“…In community settings, nonadherence to breast cancer screening guidelines contributes to the increased risk of late-stage breast cancer among women more than 40 years of age. 2 Thus, it is reasonable to target efforts to improve adherence to mammography screening guidelines in a geographic area previously found to have higher-than-expected incidence of late-stage breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…1 Mammography use reduces the likelihood of late-stage breast cancer and subsequent mortality. 2 Increased use of screening mammography during the 1990s was reported by several national studies, including the National Health Interview Survey (NHIS) 3 and the Behavioral Risk Factor Surveillance System (BRFSS). 4 By 2000, 70% of women 40 years of age and older reported being screened by mammography within the previous two years.…”
To examine racial differences in mammography use and its determinants in the City of St. Louis, MO, USA, we recruited women age 40 or older using randomdigit dialing to (1) examine the difference in mammography use between white women and African American women and (2) identify individual-and census-tract-level risk factors of nonadherence to mammography. During telephone interviews, we inquired about mammography use and several demographic, psychosocial, and health behavior variables. We determined the residential census tracts of study subjects using a geographic information system. The rate of mammography use was 68.0% among white women and 74.7% among African American women (P=0.022). African American women were more likely to have mammograms than white woman (adjusted odds ratio [OR]=1.71; 95% confidence interval [CI]=1.09-2.69). System-level barriers to mammography and heavy smoking were associated with lower mammography use among both white and African American women. Personal-experience barriers to mammography and no physician recommendation also were independently associated with mammography use among white women. White women residing within a historic geographic cluster area of late-stage breast cancer were less likely to have mammograms (adjusted OR=0.42, 95% CI=0.22-0.80), while African American women residing within a historic geographic cluster area of late-stage breast cancer were equally likely to have mammograms (adjusted OR=0.79, 95% CI=0.28-2.24). Neither individualnor census-tract-level socioeconomic status was associated with mammography screening. These findings suggest that there may be a greater need for increasing mammography use among white women, especially in the historic cluster area of latestage breast cancer in St. Louis.
“…Early diagnosis has been the major factor in the reduction of mortality and breast cancer management costs (Elmore et al, 2005;Ki-Bong Yoo et al, 2013). BSE and CBE are both non-standard and not the ideal breast cancer screening as by the time a cancer is able to be detected via CBE, it is already well defined.…”
Electrical impedance tomography (EIT) is a potential supplement for mammogram screening. This study aimed to evaluate and feasibility of EIT as opposed to mammography and to determine pain perception with both imaging methods. Women undergoing screening mammography at the Radiology Department of National University of Malaysia Medical Centre were randomly selected for EIT imaging. All women were requested to give a pain score after each imaging session. Two independent raters were chosen to define the image findings of EIT. A total of 164 women in the age range from 40 to 65-year-old participated and were divided into two groups; normal and abnormal. EIT sensitivity and specificity for rater 1 were 69.4% and 63.3, whereas for rater 2 they were 55.3% and 57.0% respectively. The reliability for each rater ranged between good to very good (p<0.05). Quantitative values of EIT showed there were significant differences in all values between groups (ANCOVA, p<0.05). Interestingly, EIT scored a median pain score of 1.51±0.75 whereas mammography scored 4.15±0.87 (Mann Whitney U test, p<0.05). From these quantitative values, EIT has the potential as a health discriminating index. Its ability to replace image findings from mammography needs further investigation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.